Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2004 4
2005 9
2006 10
2007 4
2008 7
2009 9
2010 6
2011 4
2012 1
2013 1
2014 11
2015 9
2016 5
2017 10
2018 6
2019 11
2020 16
2021 9
2022 11
2023 8
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Reversible escitalopram-induced hypothyroidism.
Eker SS, Akkaya C, Ersoy C, Sarandol A, Kirli S. Eker SS, et al. Among authors: ersoy c. Gen Hosp Psychiatry. 2010 Sep-Oct;32(5):559.e5-7. doi: 10.1016/j.genhosppsych.2010.01.003. Epub 2010 Apr 27. Gen Hosp Psychiatry. 2010. PMID: 20851281
Eighth Istanbul symposium on pediatric extracorporeal life support systems and pediatric cardiopulmonary perfusion.
Alkan-Bozkaya T, Özyüksel A, Salihoğlu E, Haydın S, Tanyıldız M, Pekkan K, Hatemi A, Türköz A, Erkan H, Aydın S, Kahraman A, Savaş A, Ersoy C, Türkoğlu H, Ündar A, Akçevin A. Alkan-Bozkaya T, et al. Among authors: ersoy c. Artif Organs. 2015 May;39(5):E49-55. doi: 10.1111/aor.12512. Artif Organs. 2015. PMID: 25953239 No abstract available.
Adrenocortical carcinoma: Single center experience.
Şişman P, Şahin AB, Peynirci H, Cander S, Gül ÖÖ, Ertürk E, Ersoy C. Şişman P, et al. Among authors: ersoy c. Turk J Urol. 2017 Dec;43(4):462-469. doi: 10.5152/tud.2017.81598. Epub 2017 Dec 1. Turk J Urol. 2017. PMID: 29201509 Free PMC article.
Neurochallenges in smart cities: state-of-the-art, perspectives, and research directions.
Özkaynak B, Aras N, Daloğlu Çetinkaya İ, Ersoy C, Durmaz İncel Ö, Koca M, Nalça İ, Onay TT, Öncü S, Ülger Vatansever B, Yücesoy E, Yücesoy CA. Özkaynak B, et al. Among authors: ersoy c. Front Neurosci. 2024 Dec 18;18:1279668. doi: 10.3389/fnins.2024.1279668. eCollection 2024. Front Neurosci. 2024. PMID: 39744330 Free PMC article. Review.
136 results